Researchers have now discovered that a conservative approach to removing the lymph nodes has lesser harm for cancer patients and has the same benefits as radical procedure.
In the Oct. 2 edition of the Journal of the American Medical Association, lead author
Dr. Roshni Rao, associate professor of surgery at UT Southwestern, and other investigators from the Harold C. Simmons Cancer Center reviewed studies on patient outcomes of women who had received various forms of surgical treatment, ranging from removal of one lymph node to prevent the spread of breast cancer to removing the entire network of lymph nodes spanning the armpits.
Analysis of Lymph Nodes Provide Correct Breast Cancer Prognosis
The removed tumour is always examined after a breast cancer operation, as its subtype can provide an indication of how aggressive the disease is.
Advertisement
Until recently, clinical practice guidelines advised complete axillary node dissection - removal of all 20-30 axillary nodes - if a woman's sentinel node biopsy was positive. The sentinel node is generally the first node to which cancer cells will spread from a primary tumor. A positive sentinel lymph node biopsy indicates the tumor has metastasized and can be used to determine the stage of the cancer. Axillary lymph nodes are distributed at the edge of the chest muscles and into the armpits and lower neck.
For women with no suspicious axillary nodes who undergo breast-conserving therapy, there is little evidence of benefit in doing a complete axillary node dissection compared with sentinel node biopsy alone, the reviewers reported. Breast conserving therapy is defined as partial mastectomy followed by whole breast radiation.
![Drug Resistance of CLL in Bone Marrow, Lymph Nodes Identified]( "Drug Resistance of CLL in Bone Marrow, Lymph Nodes Identified")
Chronic lymphocytic leukemia (CLL) recurs in the lymph nodes and bone marrow even after being cleared from the bloodstream by chemotherapy.
"In the past, axillary nodal status was a critical factor considered in therapy decisions," said Dr. Rao, a breast cancer surgeon. "With the validation of sentinel lymph node biopsy, the same staging information can be obtained with less morbidity and risk to the patient. And now that decisions regarding chemotherapy are often guided by molecular tumor profiling in an era of personalized medicine, there are other avenues to explore beyond aggressive surgeries."
To assess the effect of the guidelines, Dr. Rao and her colleagues reviewed the risks and benefits of sentinel node biopsy as compared with complete axillary node dissection in previous published research. They also compared these procedures with nonsurgical interventions (i.e., additional radiation) in women with breast cancer who do not have palpable lymph nodes or ultrasound evidence that their cancer has spread to the axillary nodes.
They also reviewed the rate of recurrence of axillary node metastases, mortality, morbidity, and complications associated with each intervention, using online medical databases. In all, more than 1,000 results were examined from 17 studies to write the JAMA review.
Avoiding axillary surgery if possible is important, Dr. Rao said, because it can cause shoulder and arm symptoms including lymphedema, severe pain or numbness, and reduced range of motion, and it generally involves longer stays in the hospital, as opposed to sentinel node surgery.
Other authors include Dr. David Euhus, professor of surgery, a Simmons Cancer Center member and part of the Division of Surgical Oncology; Dr. Charles Balch, professor of surgery, oncology and dermatology and Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research; and Helen Mayo, Faculty Associate in the UT Southwestern Library.
Visit UT Southwestern's Harold C. Simmons Cancer Center to learn more about cancer research, screening, and therapy at UT Southwestern, including highly individualized treatments at the region's only National Cancer Institute-designated center.
About UT Southwestern Medical Center
UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution's faculty includes many distinguished members, including five who have been awarded Nobel Prizes since 1985. Numbering more than 2,700, the faculty is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide medical care in 40 specialties to nearly 90,000 hospitalized patients and oversee more than 1.9 million outpatient visits a year.
Source: Newswise
Drug Resistance of CLL in Bone Marrow, Lymph Nodes Identified
Chronic lymphocytic leukemia (CLL) recurs in the lymph nodes and bone marrow even after being cleared from the bloodstream by chemotherapy.
Advertisement
"In the past, axillary nodal status was a critical factor considered in therapy decisions," said Dr. Rao, a breast cancer surgeon. "With the validation of sentinel lymph node biopsy, the same staging information can be obtained with less morbidity and risk to the patient. And now that decisions regarding chemotherapy are often guided by molecular tumor profiling in an era of personalized medicine, there are other avenues to explore beyond aggressive surgeries."
To assess the effect of the guidelines, Dr. Rao and her colleagues reviewed the risks and benefits of sentinel node biopsy as compared with complete axillary node dissection in previous published research. They also compared these procedures with nonsurgical interventions (i.e., additional radiation) in women with breast cancer who do not have palpable lymph nodes or ultrasound evidence that their cancer has spread to the axillary nodes.
They also reviewed the rate of recurrence of axillary node metastases, mortality, morbidity, and complications associated with each intervention, using online medical databases. In all, more than 1,000 results were examined from 17 studies to write the JAMA review.
Avoiding axillary surgery if possible is important, Dr. Rao said, because it can cause shoulder and arm symptoms including lymphedema, severe pain or numbness, and reduced range of motion, and it generally involves longer stays in the hospital, as opposed to sentinel node surgery.
Other authors include Dr. David Euhus, professor of surgery, a Simmons Cancer Center member and part of the Division of Surgical Oncology; Dr. Charles Balch, professor of surgery, oncology and dermatology and Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research; and Helen Mayo, Faculty Associate in the UT Southwestern Library.
Visit UT Southwestern's Harold C. Simmons Cancer Center to learn more about cancer research, screening, and therapy at UT Southwestern, including highly individualized treatments at the region's only National Cancer Institute-designated center.
About UT Southwestern Medical Center
UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution's faculty includes many distinguished members, including five who have been awarded Nobel Prizes since 1985. Numbering more than 2,700, the faculty is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide medical care in 40 specialties to nearly 90,000 hospitalized patients and oversee more than 1.9 million outpatient visits a year.
Source: Newswise
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News
Chronotherapy (the sleep-wake cycle) is observed as a valuable alternative treatment in cancer diagnosis and treatment.
A nanoengineering platform targets neutrophils, the white blood cells without killing pancreatic cancer cells paving the way for effective treatments.
The survival rates between lobectomy and wedge resection surgical procedures were found to be the same among lung cancer patients.
The mechanism by which the kinases cause inflammation has been discovered by scientists.
Pancreatic cancer cases are on the rise. The biomarker approach could reduce the chance of developing pancreatic cancer.